Thursday, 8 June 2017

Nestin: A Biomarker of Aggressive Uterine Cancers

Uterine Cancers
Cancers of the uterine corpus are the most common gynecologic cancers in the United States with incidence and mortality increasing both in the United States of America and globally.

Validated biomarkers with prognostic, predictive, and/or theragnostic value will likely play a vital role in advancing assessments of risk and guiding clinical management decision making.

Nestin is a class VI intermediate filament protein that was first described as a neural stem marker and regulates the TGFβ (transforming growth factor beta) pathway. It plays a critical role in cancer cell migration, invasion, angiogenesis, and metastasis both in vitro and in vivo.

No comments:

Post a Comment